Biomarkers

Digital Biomarkers: Is Efficient Remote Monitoring of COVID-19 Patients Primary Reason for Incessant Rise in Demand?

  • by

Biomarkers or biological markers are distinctive physiological features in an individual, which can be detected and quantified in order to gain insights about health and disease. On the other hand, digital biomarkers are defined as digital means that are employed to collect data about these… Read More »Digital Biomarkers: Is Efficient Remote Monitoring of COVID-19 Patients Primary Reason for Incessant Rise in Demand?

DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression

  • by

What You Should Know: – RenalytixAI and DaVita announce a program partnership that aims to slow kidney disease progression and improve outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). – This is the first clinical-grade program that delivers advanced early-stage… Read More »DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

  • by

As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various… Read More »30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection

  • by

What You Should Know: – Mayo Clinic announced a collaboration with Vocalis Health to to research and develop new voice-based tools for screening, detecting and monitoring patient health, beginning with a study to identify vocal biomarkers to detect pulmonary hypertension (PH). – The clinical validation… Read More »Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection

Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

  • by

What You Should Know: – Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. – MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including… Read More »Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

  • by

What You Should Know: – Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression. – In work funded through the PHDA-AWS collaboration, a research team led by… Read More »AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models